Skip to content

Prosthetic Breast Reconstruction After Mastectomy

Prosthetic Breast Reconstruction After Mastectomy: Comparison of Clinical, Anthropometric and Patient Satisfaction Parameters

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06774352
Acronym
BrREC2020
Enrollment
200
Registered
2025-01-14
Start date
2011-01-01
Completion date
2027-01-01
Last updated
2025-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Reconstruction

Brief summary

Breast cancer represents a disabling diagnosis for women, and the related destructive surgical intervention of mastectomy inevitably affects their social, relational and working life. The primary aim of post-oncological breast reconstruction is to restore volume, shape and projection as similar as possible to the contralateral breast, in unilateral mastectomies and between the two reconstructed breasts, in bilateral mastectomies, avoiding the patient the need to resort to uncomfortable and unsightly external prostheses. The study in question has a purely observational and non-interventional nature, in order to evaluate whether today the traditional EXP-IMPL prosthetic reconstructive technique represents an obsolete option or whether it can still be considered a valid alternative in clinical, anthropometric and patient satisfaction terms

Detailed description

The primary aim of post-oncological breast reconstruction is to restore volume, shape and projection as similar as possible to the contralateral breast, in unilateral mastectomies and between the two reconstructed breasts, in bilateral mastectomies, avoiding the patient the need to resort to uncomfortable and unexpectedly external prostheses. The study in question has a purely observational and non-interventional nature, in order to evaluate whether today the traditional EXP-IMPL prosthetic reconstructive technique represents an obsolete option or whether it can still be considered a valid alternative in clinical, anthropometric and patient satisfaction terms. In order to evaluate outcomes in prosthetic breast reconstructions immediate (DTI - Direct to Implant) and in two surgical stages (EXP-IMPL - expander/prosthesis), after mastectomy, the aforementioned data will be subjected to appropriate statistical analysis

Interventions

None listed

Sponsors

IRCCS Azienda Ospedaliero-Universitaria di Bologna
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Sex F * Patients undergoing mastectomy (R-m, SS-m, NSS-m) * Age 18 - 70 * Prosthetic breast reconstruction (DTI or EXP-IMPL) * Written informed consent

Exclusion criteria

* Autologous breast reconstruction

Design outcomes

Primary

MeasureTime frameDescription
Technical SuccessFrom the first patient entrolled, up to the 200th patient, an average of 2 yearsTechnical Success is defined by number of reinterveions, major complication and the necessity to change approach.

Secondary

MeasureTime frameDescription
Patient satisfactionFrom the first patient enrolled, up to the 200th. An average of 2 yearsSatisfaction is measured by specific Q-Breast questionnaire

Countries

Italy

Contacts

Primary ContactMarco Pignatti, MD
marco.pignatti@unibo.it+39 051 2143614

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026